Eosinophilic oesophagitis: Treatment using Montelukast [4]

Gut

Volumn 52, Issue 8, 2003, Pages 1228-1229

  Sinharay, R ^a  

^a ROYAL GWENT HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CROMOGLYCATE DISODIUM; KETOTIFEN; MONTELUKAST; ZAFIRLUKAST;

CHURG STRAUSS SYNDROME; CLINICAL FEATURE; DRUG EFFECT; DRUG MECHANISM; EOSINOPHILIC ESOPHAGITIS; ESOPHAGUS DISEASE; HUMAN; LETTER; LOEFFLER PNEUMONIA; MYALGIA; NAUSEA; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SIDE EFFECT;

ACETATES; EOSINOPHILIA; ESOPHAGITIS; HUMANS; LEUKOTRIENE ANTAGONISTS; QUINOLINES;

EID: 0038637341     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.52.8.1228     Document Type: Letter

References (9)

1. Bisgaard H. Pathophysiology of the cysteinyl leukotrienes and effects of leukotriene receptor antagonists in asthma. Allergy 2001;56(suppl 66):7-11.
2. Daneshjoo R, J Talley N. Eosinophilic gastroenteritis. Curr Gastroenterol Rep 2002;4:366-72.
3. Neustrom MR, Friesen C. Treatment of eosinophilic gastroenteritis with montelukast. J Allergy Clin Immunol 1999;104:506.
4. Sampson A, Holgate S. Leukotriene modifiers in the traetment of asthma. BMJ 1998;316:1257-8.
5. Wechsler ME, Garpestad E, Flier SR, et al. Pulmonary infiltrates, eosinophilia and cardiomyopathy. JAMA 1998;279:455-7.
6. Churg J, Churg A. Zafirlukast and Churg-Strauss syndrome. JAMA 1998;279:1949-50.
7. Committee on the Safety of Medicines. Leukotriene antagonists: a new class of. Probl Pharmacovigilance 1998;24:14.
8. Tuggey JM, Hosker HSR. Churg-Strauss syndrome associated with montelukast therapy. Thorax 2000;55:805-6.
9. Daikh BE, Ryan CK, Schwartz RH. Montelukast reduces peripheral blood eosinophilia but not tissue eosinophilia or symptoms in a patient with eosinophilic gastroenteritis and esophageal stricture. Ann Allergy Asthma Immunol 2003;90:23-7.